Chronic systemic aspergillosis in a patient with acute myeloid leukemia.
Systemic aspergillosis is a well-recognized complication of chemotherapy-induced neutropenia. In this report a patient with acute myeloid leukemia is described in whom a chronic aspergillosis with systemic involvement developed after recovery from neutropenia following intensive chemotherapy and allogeneic bone marrow transplantation. The clinical features of a chronic course of systemic aspergillosis suggest a distinct clinical entity comparable to chronic systemic candidiasis.
Kern
W
W
Department of Hematology and Oncology, Georg-August-University, Göttingen, Germany.
Braess
J
J
Bertz
H
H
Pott
C
C
Schleyer
E
E
Finke
J
J
Rüchel
R
R
Hiddemann
W
W
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology*; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003131:Combined Modality Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications*